TB-500 (Thymosin Beta-4)
A synthetic peptide fragment that promotes tissue repair, flexibility, and recovery
Quick Answer
TB-500 is a synthetic 43-amino acid peptide derived from thymosin beta-4, a naturally occurring protein that regulates cell migration and tissue repair. Research shows it accelerates wound healing, promotes angiogenesis (new blood vessel formation), and reduces inflammation. Common protocols use 2-5mg twice weekly for 4-8 weeks. Unlike BPC-157 which targets specific injury sites, TB-500 works systemically. It's not FDA-approved and carries more regulatory restrictions than BPC-157. Most evidence is from animal studies; human data is limited.
Emerging
New research, promising but early
Safety: TB-500 appears well-tolerated in available research, but human clinical data is limited. Not FDA-approved for human use.
What Is This?
TB-500 (Thymosin Beta-4 acetate) is a synthetic peptide fragment derived from thymosin beta-4, one of the most abundant intracellular proteins in mammalian cells. Originally identified in the thymus gland, thymosin beta-4 plays critical roles in cell migration, blood vessel formation, and tissue regeneration.
Key facts:
- Origin: Synthetic fragment of naturally occurring thymosin beta-4
- Size: 43 amino acids
- Mechanism: Regulates actin (cellular skeleton protein), promoting cell migration and repair
- Systemic action: Works throughout the body, not just at injection site
- Tissue repair: Accelerates healing of tendons, ligaments, muscles
- Cardiac repair: Studied for post-heart attack recovery
- Wound healing: Promotes skin and soft tissue repair
- Flexibility: Users report improved joint mobility
- Neuroprotection: Animal studies show brain repair potential
How It Works
TB-500 works through several interconnected mechanisms:
Actin Regulation: Thymosin beta-4 is the primary regulator of G-actin (monomeric actin) in cells. By sequestering actin, TB-500 promotes cell motility, allowing repair cells to migrate to injury sites more efficiently. This is why it's particularly effective for tissue repair.
Angiogenesis: TB-500 stimulates the growth of new blood vessels, ensuring oxygen and nutrients reach damaged tissues. This enhanced blood flow supports tissue regeneration and accelerates recovery. Studies show improved cardiac function after ischemic injury through this mechanism.
Anti-Inflammatory Effects: Reduces inflammatory markers and oxidative damage, particularly in cardiac and nervous system tissue. This dampens chronic inflammation that can impair healing.
Cell Migration & Proliferation: Increases proliferation and migration of fibroblasts (cells that build connective tissue), epithelial cells (blood vessel repair), and neural cells. Research shows TB-500 enhances fibroblast migration in vitro, accelerating wound closure.
Why it differs from BPC-157:
- BPC-157: Derived from gastric proteins, works locally at injury site, more gut-specific benefits
- TB-500: Derived from thymosin beta-4, works systemically, stronger on flexibility and cardiovascular effects
- Many users combine both for synergistic healing
How to Start
Understand the regulatory landscape
TB-500 is not FDA-approved and is sold as a research chemical only. It's banned in competitive sports (WADA). Ensure you understand the legal and health implications in your jurisdiction.
Tips:
- •Not legal for human therapeutic use
- •Athletes subject to drug testing should avoid
- •Consult a physician knowledgeable about peptides
Source from a reputable vendor
Product quality varies dramatically. Low-quality TB-500 may be contaminated, underdosed, or completely inactive. Look for vendors with third-party testing and certificates of analysis.
Tips:
- •Request certificate of analysis (CoA)
- •Look for HPLC purity testing (>98%)
- •Avoid suspiciously cheap products
Reconstitute properly
TB-500 typically comes as lyophilized (freeze-dried) powder. Reconstitute with bacteriostatic water, injecting slowly down the vial wall to avoid damaging the peptide.
Tips:
- •Use bacteriostatic water, not saline
- •Store reconstituted peptide refrigerated
- •Use within 3-4 weeks after reconstitution
Follow a loading protocol
Common protocols start with a loading phase of 2-5mg twice weekly for 4 weeks, then reduce to 1-2mg weekly for maintenance. TB-500 works systemically, injection site doesn't need to be near the injury.
Tips:
- •Subcutaneous injection in abdomen is most common
- •Split weekly dose into 2 injections
- •Loading phase accelerates initial healing response
Monitor and adjust
Most users report noticeable improvements in 2-4 weeks. Acute injuries may respond faster than chronic conditions. Track your symptoms and adjust protocol as needed.
Tips:
- •Keep a symptom journal
- •Take progress photos if applicable
- •Consider bloodwork before and after extended use
What to Expect
Initial administration
Loading phase begins. May notice subtle improvements in inflammation or flexibility. Some users report increased energy or well-being. Injection site reactions (redness, mild swelling) are common and temporary.
Healing acceleration
Most users report noticeable improvements in pain, mobility, or injury healing. Chronic issues may take longer. Flexibility improvements are commonly reported during this phase.
Continued progress
Transition to maintenance dosing. Healing continues as collagen remodels and blood vessel formation stabilizes. Significant injuries may require the full 8-week protocol.
Maintenance or cycling off
Some users continue low-dose maintenance (2-6mg/month). Others cycle off completely. Benefits from tissue repair tend to persist after stopping. No PCT required, TB-500 doesn't affect hormones.
Dosing Information
Recommended Dose
2-5mg twice weekly (loading), then 1-2mg weekly (maintenance)
Range
4-10mg per week during loading; 2-6mg per month maintenance
- •Loading phase: 4-8 weeks at higher dose
- •Maintenance phase: reduced dose after improvement
- •Subcutaneous injection is most common route
- •Can inject anywhere, doesn't need to be near injury
- •Often combined with BPC-157 for synergistic effects
TB-500 is not FDA-approved for human use. It is sold as a research chemical only. Consult a physician before use. Avoid if you have or have had cancer.
Practical Details
Timing
Inject at consistent times. Many split weekly dose into 2 injections (e.g., Monday/Thursday). Can be taken any time of day.
Duration
Typical protocols run 4-8 weeks loading phase, followed by optional maintenance. Some users cycle on/off. No hormonal suppression, so no PCT needed.
Cost
$50-150 per 5mg vial
Full loading protocol may require 4-8 vials ($200-600+ total). Prices vary by vendor and purity. Bacteriostatic water, syringes, and alcohol swabs add ~$20-30.
Risks & Considerations
Potential Risks
- •Limited long-term human safety data
- •Theoretical cancer concern due to angiogenesis (no evidence in humans)
- •Unregulated market with quality/contamination risks
- •Legal issues in competitive sports (WADA banned)
- •Not FDA-approved for human use
- •Injection site reactions possible
Possible Side Effects
- •Injection site reactions: redness, swelling, tenderness (common, temporary)
- •Headache in first few days (some users)
- •Lightheadedness post-injection (especially if injected rapidly)
- •Temporary fatigue during initial healing response
- •Mild drop in blood pressure (rare, due to vasodilation)
Who Should Avoid This
- •Active cancer or history of cancer (theoretical angiogenesis concern)
- •Pregnancy or breastfeeding
- •Competitive athletes subject to WADA testing
- •Hypersensitivity to thymosin beta-4 or related peptides
- •Severe cardiovascular disease (consult physician)
Key Research
The effect of thymosin treatment of venous ulcers
Annals of the New York Academy of Sciences, 2010
Phase II trial showed topical thymosin beta-4 was well-tolerated and achieved complete wound healing in ~25% of patients within 3 months, especially those with small to moderate sized wounds.
View StudyThymosin beta4 and cardiac repair
Annals of the New York Academy of Sciences, 2010
Thymosin beta-4 inhibits myocardial cell death, stimulates blood vessel growth, and activates cardiac progenitors, the first molecule shown to initiate simultaneous myocardial and vascular regeneration.
View StudyThymosin beta4: a candidate for treatment of stroke?
Annals of the New York Academy of Sciences, 2010
Thymosin beta-4 stimulates vasculogenesis, angiogenesis, and arteriogenesis, suggesting potential to enhance neurological recovery after stroke by promoting neurogenesis and axonal sprouting.
View StudyAnti-aging potential of thymosin beta-4
International Journal of Molecular Sciences, 2021
Review describes TB4's potential to influence senescence through tissue regeneration in heart and brain, suggesting anti-aging applications warrant further study.
View StudyFrequently Asked Questions
What's the difference between TB-500 and BPC-157?
Both promote healing but through different mechanisms. TB-500 (from thymosin beta-4) works systemically throughout the body, promoting angiogenesis and cell migration. BPC-157 (from gastric proteins) works more locally and has additional gut-healing benefits. TB-500 is better for flexibility and cardiovascular support; BPC-157 is often preferred for tendons and gut issues. Many users combine both for synergistic effects, they target different pathways.
Is TB-500 legal?
TB-500 exists in a legal gray area. It's not FDA-approved for human use and is sold as a "research chemical." In 2023, the FDA prohibited compounding pharmacies from producing it. It's banned by WADA for competitive athletes. Personal possession for research is generally not prosecuted, but selling for human consumption is illegal. Check your local laws and understand the risks.
Does TB-500 cause cancer?
There's no evidence that TB-500 causes cancer in humans. The concern is theoretical, TB-500 promotes angiogenesis (blood vessel growth), and tumors require blood vessels to grow. However, no studies have shown TB-500 initiates or accelerates cancer. As a precaution, those with active cancer or recent cancer history should avoid it until more data is available.
Do I need to inject near the injury?
No. Unlike some localized treatments, TB-500 works systemically. The peptide circulates throughout your body regardless of injection site. Most users inject subcutaneously in the abdomen for convenience. Injecting near an injury doesn't appear to provide additional benefit.
How long until I see results?
Most users report noticeable improvements within 2-4 weeks of starting a loading protocol. Acute injuries often respond faster than chronic conditions. Full benefits from tissue remodeling may take 6-8 weeks. Some people respond better than others, if you see no benefit after 4-6 weeks at proper dosing, it may not be effective for your condition.
Can I stack TB-500 with BPC-157?
Yes, this is a common combination. They work through different mechanisms, TB-500 for systemic healing and angiogenesis, BPC-157 for local tissue repair and gut health. Many users report synergistic benefits. They can be injected separately or some combine them in the same syringe (though this is less studied). No negative interactions have been reported.
Sources
Related Interventions
Disclaimer: This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider before starting any new health practice or supplement. Evidence levels and recommendations can change, this content was last updated December 2025.